BNP Paribas Exane re-initiated coverage of Sonova (SONVY) with an Underperform rating and CHF 195 price target The firm cites the company’s “weak” end markets and intense competition for the sell rating.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SONVY: